Kemal Yelekçi (Kemal Yelekci)

Loop profile ResearcherID ORCID

Publication Activity (10 Years)

Years Active: 2017-2022
Publications (10 Years): 12

Top Venues

Journal of biomolecular structure & dynamics

Molecular diversity

Journal of medicinal chemistry

Kadir Has Üniversitesi

Ohio University (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Kadir Has Üniversitesi Jul 15 2001

Turkey

Chairman :: Bioinformatics and Genetics

Education History

Ohio University Aug 30 1983 - Mar 21 1987

United States

PHD :: Chemistry

Middle East Technical University Jul 22 1973 - Feb 14 1979

Turkey

BSC :: Chemistry

Publications

Sarah Boumezber, Kemal Yelekçi
Screening of novel and selective inhibitors for neuronal nitric oxide synthase (nNOS) via structure-based drug design techniques. Journal of biomolecular structure & dynamics (2022)
Bahadır Bülbül, Kai Ding, Chang-Guo Zhan, Gamze Çiftçi, Kemal Yelekçi, Merve Gürboğa, Özlem Bingöl Özakpınar, Esra Aydemir, Deniz Baybağ, Fikrettin Şahin, Necla Kulabaş, Sinem Helvacıoğlu, Mohammad Charehsaz, Esra Tatar, Süheyla Özbey, İlkay Küçükgüzel
Novel 1,2,4-triazoles derived from Ibuprofen: synthesis and in vitro evaluation of their mPGES-1 inhibitory and antiproliferative activity. Molecular diversity (2022)
Safana Albayati, Abdullahi Ibrahim Uba, Kemal Yelekçi
Potential inhibitors of methionine aminopeptidase type II identified via structure-based pharmacophore modeling. Molecular diversity (2021)
Umut Salgin-Goksen, Gokcen Telli, Acelya Erikci, Ezgi Dedecengiz, Banu Cahide Tel, F Betul Kaynak, Kemal Yelekçi, Gulberk Ucar, Nesrin Gokhan-Kelekci
New 2-Pyrazoline and Hydrazone Derivatives as Potent and Selective Monoamine Oxidase A Inhibitors. Journal of medicinal chemistry 64 (4) (2021)
Ammar D Elmezayen, Kemal Yelekçi
Homology modeling and in silico design of novel and potential dual-acting inhibitors of human histone deacetylases HDAC5 and HDAC9 isozymes. Journal of biomolecular structure & dynamics 39 (17) (2020)
Anas Al-Obaidi, Ammar D Elmezayen, Kemal Yelekçi
Homology modeling of human GABA-AT and devise some novel and potent inhibitors via computer-aided drug design techniques. Journal of biomolecular structure & dynamics 39 (11) (2020)
Ammar D Elmezayen, Anas Al-Obaidi, Alp Tegin Şahin, Kemal Yelekçi
Drug repurposing for coronavirus (COVID-19): in silico screening of known drugs against coronavirus 3CL hydrolase and protease enzymes. Journal of biomolecular structure & dynamics 39 (8) (2020)
Abdullahi Ibrahim Uba, Jackson Weako, Özlem Keskin, Attila Gürsoy, Kemal Yelekçi
Examining the stability of binding modes of the co-crystallized inhibitors of human HDAC8 by molecular dynamics simulation. Journal of biomolecular structure & dynamics 38 (6) (2019)
Abdullahi Ibrahim Uba, Kemal Yelekçi
Homology modeling of human histone deacetylase 10 and design of potential selective inhibitors. Journal of biomolecular structure & dynamics 37 (14) (2019)
Abdullahi Ibrahim Uba, Kemal Yelekçi
Crystallographic structure versus homology model: a case study of molecular dynamics simulation of human and zebrafish histone deacetylase 10. Journal of biomolecular structure & dynamics 38 (15) (2019)
Teodora Djikic, Yasmina Martí, Francesca Spyrakis, Thorsten Lau, Paolo Benedetti, Gavin Davey, Patrick Schloss, Kemal Yelekçi
Human dopamine transporter: the first implementation of a combined in silico/in vitro approach revealing the substrate and inhibitor specificities. Journal of biomolecular structure & dynamics 37 (2) (2018)
Abdullahi Ibrahim Uba, Kemal Yelekçi
Identification of potential isoform-selective histone deacetylase inhibitors for cancer therapy: a combined approach of structure-based virtual screening, ADMET prediction and molecular dynamics simulation assay. Journal of biomolecular structure & dynamics 36 (12) (2017)

Kemal Yelekçi.css-eqlu8i{font-size:small;padding-left:4px;} (Kemal Yelekci)

Publication Activity (10 Years)

Top Topics

Top Venues

Kemal Yelekçi (Kemal Yelekci)